aspen ciprofloxacin
pharmacy retailing (nz) ltd t/a healthcare logistics - ciprofloxacin 2 mg/ml; - solution for injection - 2 mg/ml - active: ciprofloxacin 2 mg/ml excipient: glucose monohydrate lactic acid water for injection - hospitalised adult patients in whom oral ciprofloxacin is indicated but cannot be administered or where the oral form is inappropriate. for the treatment of serious or life threatening infections due to sensitive organisms involving the following organ systems: - lower respiratory tract infections (gram-negative organisms) - skin and skin structure - septicaemia - bone and joint - urinary tract ciprofloxacin is suitable to treat mixed infections caused by susceptible strains of both gram-negative and gram-positive aerobic bacteria. if anaerobic organisms are suspected as accompanying aetiologic agents, additional therapy should be considered.
ciprofloxacin 100mg tablets
alliance healthcare (distribution) ltd - ciprofloxacin hydrochloride - oral tablet - 100mg
ciprofloxacin 250mg tablets
viatris uk healthcare ltd - ciprofloxacin hydrochloride - oral tablet - 250mg
ciprofloxacin 250mg tablets
alliance healthcare (distribution) ltd - ciprofloxacin hydrochloride - oral tablet - 250mg
ciprofloxacin 500mg tablets
viatris uk healthcare ltd - ciprofloxacin hydrochloride - oral tablet - 500mg
ciprofloxacin 500mg tablets
alliance healthcare (distribution) ltd - ciprofloxacin hydrochloride - oral tablet - 500mg
ciprofloxacin 750mg tablets
alliance healthcare (distribution) ltd - ciprofloxacin hydrochloride - oral tablet - 750mg
ciprofloxacin 100mg tablets
phoenix healthcare distribution ltd - ciprofloxacin hydrochloride - oral tablet - 100mg
ciprofloxacin 500mg tablets
phoenix healthcare distribution ltd - ciprofloxacin hydrochloride - oral tablet - 500mg
levofloxacin 250mg tablets
alliance healthcare (distribution) ltd - levofloxacin hemihydrate - oral tablet - 250mg